Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.

Pratima ChowdaryMargareta HolmströmJohnny N MahlanguMargaret C OzeloIngrid Pabinger-FaschingK John PasiMargaret V RagniAmy ShapiroChris BarnowskiStefan Lethagen

Published in: Research and practice in thrombosis and haemostasis (2022)

rFVIIIFc and rFIXFc were efficacious and well tolerated for the management of perioperative hemostasis across a wide spectrum of major and minor surgeries in hemophilia.

Keyphrases

minimally invasive
randomized controlled trial
coronary artery bypass
systematic review
cardiac surgery
patients undergoing
big data
surgical site infection
acute kidney injury
coronary artery disease
cell free
percutaneous coronary intervention
data analysis